Mesoblast Limited Selected As US Stem Cell Market Innovation of the Year by Frost & Sullivan
Melbourne, Nov 14, 2008 (ABN Newswire) - Regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), announced today that its adult stem cell technology platform has been awarded the 2008 Frost & Sullivan United States Stem Cell Market Technology Innovation of the Year.